Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity
Open Access
Abstract
Obtaining sufficient numbers of functional natural killer (NK) cells is crucial for the success of NK-cell-based adoptive immunotherapies. While expansion from peripheral blood (PB) is the current method of choice, ex vivo generation of NK cells from hematopoietic stem and progenitor cells (HSCs) may constitute an attractive alternative. Thereby, HSCs mobilized into peripheral blood (PB-CD34+) represent a valuable starting material, but the rather poor and donor-dependent differentiation of isolated PB-CD34+ cells into NK cells observed in earlier studies still represents a major hurdle. Here, we report a refined approach based on ex vivo culture of PB-CD34+ cells with optimized cytokine cocktails that reliably generates functionally mature NK cells, as assessed by analyzing NK-cell-associated surface markers and cytotoxicity. To further enhance NK cell expansion, we generated K562 feeder cells co-expressing 4-1BB ligand and membrane-anchored IL-15 and IL-21. Co-culture of PB-derived NK cells and NK cells that were ex-vivo-differentiated from HSCs with these feeder cells dramatically improved NK cell expansion, and fully compensated for donor-to-donor variability observed during only cytokine-based propagation. Our findings suggest mobilized PB-CD34+ cells expanded and differentiated according to this two-step protocol as a promising source for the generation of allogeneic NK cells for adoptive cancer immunotherapy.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (WE 2589/4-1, GRK 1172/2)
- Hessisches Ministerium für Wissenschaft und Kunst (III L 5-518/17.004 (2013))
This publication has 56 references indexed in Scilit:
- Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull MicePLOS ONE, 2013
- EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor CellsPLOS ONE, 2013
- IGF-1 promotes the development and cytotoxic activity of human NK cellsNature Communications, 2013
- Natural killer–cell differentiation by myeloid progenitorsBlood, 2011
- Pluripotent stem cell-derived natural killer cells for cancer therapyTranslational Research, 2010
- Nfil3/E4bp4 is required for the development and maturation of NK cells in vivoJournal of Experimental Medicine, 2009
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Interleukin‐21 activates human natural killer cells and modulates their surface receptor expressionImmunology, 2008
- The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptorsArthritis Research & Therapy, 2007